About this trial

The purpose of this study is to evaluate patient-reported post-operative pain scores following minimally invasive tubal sterilization procedures to determine if a multimodal, non-opioid pain control regimen is non-inferior to a pain control regimen including opioids.

The study team hypothesizes that with extensive counseling on pain management, multimodal medication use, and expectation with non-opioid methods can effectively eliminate the need for opioid prescriptions after laparoscopic salpingectomy.

Eligibility criteria

Qualifiers

Individuals with a fallopian tube (unilateral and/or bilateral)

Age 18 years old and above

Undergoing minimally invasive (laparoscopic or robotic) unilateral or bilateral salpingectomy or other tubal sterilization procedure as the primary procedure

Benign indications for salpingectomy/tubal sterilization

Disqualifiers

Chronic pain syndromes patients including fibromyalgia

Patients currently on long-term (i.e. for more than three months) opioid use

Conversion to laparotomy

Allergy or other contraindication to the prescribed medications such as acetaminophen or oxycodone

Trial design

Treatments tested in this trial

  • Acetaminophen
  • Ibuprofen
  • Oxycodone

Treatment groups

38 Participants
are divided into 2 treatment groups

Locations

1
Johns Hopkins Bayview Medical Center21224, BaltimoreMaryland, United States

Sponsors and collaborators

Johns Hopkins University

Lead sponsor